ClinicalTrialsFinder

HER2-positive Metastatic Breast Cancer Clinical Trials in Washington D.C., District of Columbia

1 recruitingWashington D.C., District of Columbia

Showing 1–1 of 1 trials

Recruiting

QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer

HER2-positive Metastatic Breast Cancer
Abramson Cancer Center at Penn Medicine200 enrolled36 locationsNCT06551116